Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas

被引:9
|
作者
Catarino, Rosa [1 ]
Vassilakos, Pierre [2 ]
Jinoro, Jeromine [3 ]
Broquet, Celine [1 ]
Benski, Anne-Caroline [1 ,3 ]
Meyer-Hamme, Ulrike [1 ]
Petignat, Patrick [1 ]
机构
[1] Univ Hosp Geneva, Div Gynaecol, Dept Obstet & Gynaecol, Blvd Cluse 30, CH-1206 Geneva, Switzerland
[2] Geneva Fdn Med Educ & Res, Route Ferney 150, CH-1211 Geneva, Switzerland
[3] St Damien Med Ctr, Ambanja, Madagascar
关键词
Cervical cancer; Developing country; HPV testing; HPV vaccination; Prevention; ANYPLEX II HPV28; CERVICAL NEOPLASIA; MULTIPLE TYPES; INFECTION; AGE; CANCER; POPULATION; HEALTH; ASSAY;
D O I
10.1016/j.canep.2016.04.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cervical cancer (CC) is the most common cancer among sub-Saharan African women. Efficient, global reduction of CC will only be achieved by incorporation of human papillomavirus (HPV) vaccination into existing programmes. We aimed to investigate the overall and type-specific prevalences and distributions of oncogenic HPVs. Methods: A total of 1081 women aged 30-65 years were recruited to three sequential studies in Madagascar. Demographic and historical data were obtained from participants, and specimens were self-collected for HPV testing using real-time polymerase chain reaction. HPV-positive women underwent detailed pelvic examination, visual inspection of the cervix with acetic acid, biopsy, and endocervical curettage. Data were analysed using chi(2) and t-tests, and logistic regression. Results: The prevalence of all 19 high-risk types of HPV was 39.3%. There were no differences in the prevalences of HPV and CC between rural and urban Malagasy women. The most common high-risk HPV types were HPV-53 (6.2%) and HPV-68 (5.8%), followed by HPV-52 (5.2%), HPV-35 (4.5%), HPV-73 (3.4%), HPV-31 (3.4%), HPV-16 (3.1%), and HPV-18 (3.1%). The prevalence of cervical intraepithelial neoplasia >= grade 2 (CIN2+) was 9.4%. CIN1-CIN3 lesions were more common in women in their 30s. The median age of participants with CIN2+ was 44 years (range 37-55). Overall, 25.8% of CIN2+ cases were associated with HPV-16/18. Conclusions: This study provides evidence to support the introduction of HPV vaccination in eastern African countries such as Madagascar. Further studies are needed to screen younger women and adolescents, to provide a global vision of HPV genotype distributions and to maximize the impact of HPV vaccination. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [1] Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review
    Ouedraogo, Rogomenoma Alice
    Kande, Ali
    Nadembega, Wendyam Marie Christelle
    Ouermi, Djeneba
    Zohoncon, Theodora Mahoukede
    Djigma, Florencia Wendkuuni
    Ouedraogo, Charlemagne Marie Ragnag-Newende
    Lompo, Olga Melanie
    Simpore, Jacques
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
  • [2] Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review
    Rogomenoma Alice Ouedraogo
    Ali Kande
    Wendyam Marie Christelle Nadembega
    Djeneba Ouermi
    Théodora Mahoukèdè Zohoncon
    Florencia Wendkuuni Djigma
    Charlemagne Marie Ragnag-Newende Ouedraogo
    Olga Mélanie Lompo
    Jacques Simpore
    Journal of the Egyptian National Cancer Institute, 35
  • [3] Type-specific prevalence of human papillomavirus among women with abnormal cytology in Jordan
    Freij, M. A.
    Saleh, H. H.
    Farsakh, H. A. A.
    Khadra, M. M.
    Ijmail, A. A.
    Rahall, B. O.
    Waldali, M. H.
    Najeeb, N. S.
    Tahtamouni, L. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (06) : 901 - 904
  • [4] Differences in Factors Associated With High- and Low-Risk Oral Human Papillomavirus Genotypes in Men
    Bettampadi, Deepti
    Dickey, Brittney
    Abrahamsen, Martha
    Sirak, Bradley
    Baggio, Maria Luiza
    Galan, Lenice
    Silva, Roberto Carvalho
    Villa, Luisa
    Ponce, Eduardo Lazcano
    Giuliano, Anna R.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (12): : 2099 - 2107
  • [5] Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China
    Shuyama, K.
    Castillo, A.
    Aguayo, F.
    Sun, Q.
    Khan, N.
    Koriyama, C.
    Akiba, S.
    BRITISH JOURNAL OF CANCER, 2007, 96 (10) : 1554 - 1559
  • [6] Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China
    K Shuyama
    A Castillo
    F Aguayo
    Q Sun
    N Khan
    C Koriyama
    S Akiba
    British Journal of Cancer, 2007, 96 : 1554 - 1559
  • [7] Type-specific Prevalence of Human Papillomavirus by Cervical Cytology among Women in Brasov, Romania
    Moga, Marius Alexandru
    Irimie, Marius
    Oanta, Alexandru
    Pascu, Alina
    Burtea, Victoria
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6887 - 6892
  • [8] Orogenital Human Papillomavirus Infection and Vaccines: A Survey of High- and Low-Risk Genotypes Not Included in Vaccines
    Butta, Michela
    Serra, Nicola
    Panzarella, Vera
    Fasciana, Teresa Maria Assunta
    Campisi, Giuseppina
    Capra, Giuseppina
    VACCINES, 2023, 11 (09)
  • [9] Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection
    Kelly, Helen
    Faust, Helena
    Chikandiwa, Admire
    Ngou, Jean
    Weiss, Helen A.
    Segondy, Michel
    Dillner, Joakim
    Delany-Moretlwe, Sinead
    Mayaud, Philippe
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (06): : 927 - 936
  • [10] Human Papillomavirus Infection Low-Risk and High-Risk Genotypes in Women in Catania, Sicily
    Agodi, Antonella
    Barchitta, Martina
    La Rosa, Nadia
    Cipresso, Rosalba
    Guarnaccia, Mariella
    Caruso, Melania
    Castiglione, Maria Grazia
    Ettore, Giuseppe
    Travali, Salvatore
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1094 - 1098